The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer
Umar Raza(Bilkent University), Özgür Şahin(Medical University of South Carolina)
Cited by 59
Related Papers
Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
|Oncogene|2012|286
Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer
|Breast Cancer Research and Treatment|2022|58